Interleukin-13 but not interleukin-4 prolongs eosinophil survival and induces eosinophil chemotaxis
- PMID: 9144009
- DOI: 10.2169/internalmedicine.36.179
Interleukin-13 but not interleukin-4 prolongs eosinophil survival and induces eosinophil chemotaxis
Abstract
The effects of recombinant human (rh) interleukin (IL)-4 or rhIL-13 on survival, and chemotactic activity of human eosinophils were examined. Only rhIL-13 prolonged eosinophil survival in a dose-dependent manner above 3 ng/ml. Eosinophil survival induced by rhIL-13 was inhibited by monoclonal antibodies (mAbs) against IL-3 (p < 0.01) and granulocyte-macrophage colony-stimulating factor (GM-CSF) (p < 0.05), suggesting that rhIL-13 induced IL-3 and GM-CSF production from eosinophils and an autocrine mechanism is responsible for the eosinophil survival. The effects of rhIL-13 on eosinophil chemotactic activity were also examined. rhIL-13 showed chemotactic activity for eosinophils in a dose-dependent manner. Checkerboard analysis revealed that eosinophil migration was dependent on the concentration gradient, confirming that rhIL-13 is a chemotactic factor. rhIL-4 showed no effects. IL-13 may play an important role in the survival and recruitment of eosinophils in allergic diseases.
Similar articles
-
Human interleukin-5 (IL-5) regulates the production of eosinophils in human bone marrow cultures: comparison and interaction with IL-1, IL-3, IL-6, and GMCSF.Blood. 1989 May 1;73(6):1504-12. Blood. 1989. PMID: 2653458
-
Effect of butyric acid on induction of differentiation into eosinophil-like cells in human eosinophilic leukemia cells, EoL-1 cell line: possible role of granulocyte-macrophage colony-stimulating factor as an autocrine differentiating factor.Int Arch Allergy Immunol. 1993;100(3):240-7. doi: 10.1159/000236418. Int Arch Allergy Immunol. 1993. PMID: 8453311
-
Modulation and induction of eosinophil chemotaxis by granulocyte-macrophage colony-stimulating factor and interleukin-3.Blood. 1991 Jun 15;77(12):2694-700. Blood. 1991. PMID: 1646045
-
[Role of eosinophils in allergic inflammation].Yakugaku Zasshi. 2005 Sep;125(9):717-23. doi: 10.1248/yakushi.125.717. Yakugaku Zasshi. 2005. PMID: 16141691 Review. Japanese.
-
Mechanisms and pharmacological manipulation of eosinophil accumulation in vivo.Trends Pharmacol Sci. 1995 Dec;16(12):418-23. doi: 10.1016/s0165-6147(00)89092-6. Trends Pharmacol Sci. 1995. PMID: 8578615 Review.
Cited by
-
Stable and exacerbation period serum cytokine and periostin levels of the five distinct phenotypes of severe asthma.Turk J Med Sci. 2022 Aug;52(4):1148-1159. doi: 10.55730/1300-0144.5418. Epub 2022 Aug 10. Turk J Med Sci. 2022. PMID: 36326393 Free PMC article.
-
IL-4 engagement of the type I IL-4 receptor complex enhances mouse eosinophil migration to eotaxin-1 in vitro.PLoS One. 2012;7(6):e39673. doi: 10.1371/journal.pone.0039673. Epub 2012 Jun 28. PLoS One. 2012. PMID: 22761864 Free PMC article.
-
Role of Macrophages in the Repair Process during the Tissue Migrating and Resident Helminth Infections.Biomed Res Int. 2016;2016:8634603. doi: 10.1155/2016/8634603. Epub 2016 Aug 25. Biomed Res Int. 2016. PMID: 27648452 Free PMC article. Review.
-
Eosinophils and allergic airway disease: there is more to the story.Trends Immunol. 2010 Jan;31(1):39-44. doi: 10.1016/j.it.2009.10.001. Epub 2009 Nov 18. Trends Immunol. 2010. PMID: 19926338 Free PMC article. Review.
-
A randomized, placebo-controlled trial evaluating effects of lebrikizumab on airway eosinophilic inflammation and remodelling in uncontrolled asthma (CLAVIER).Clin Exp Allergy. 2020 Dec;50(12):1342-1351. doi: 10.1111/cea.13731. Epub 2020 Oct 4. Clin Exp Allergy. 2020. PMID: 32909660 Free PMC article. Clinical Trial.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources